Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.025
+0.075 (3.85%)
May 8, 2025, 4:00 PM EDT - Market closed
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $56.27 million as of May 8, 2025. Its market cap has increased by 9.44% in one year.
Market Cap
56.27M
Enterprise Value
46.54M
1-Year Change
9.44%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $56.27M, a decrease of -54.86%. That is a compound annual growth rate of -17.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 54.18M | -5.43% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.85B |
| Johnson & Johnson | 371.67B |
| UnitedHealth Group | 359.09B |
| AbbVie | 331.06B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.50B |
| AstraZeneca | 221.83B |
| Novartis AG | 220.92B |